Humanigen (Formerly Known As KaloBios Pharmaceuticals, Inc.)

1000 Marina Boulevard
Suite 250
Brisbane
California
94005-1878
United States

Tel: 650-243-3100
Fax: 650-243-3260

Email: admin@kalobios.com

Show jobs for this employer

About Humanigen (Formerly Known As KaloBios Pharmaceuticals, Inc.)

Humanigen, Inc. is a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases through innovative, accelerated business models. Lead compounds in the portfolio are benznidazole for the potential treatment of Chagas disease in the U.S., and the proprietary monoclonal antibodies, lenzilumab and ifabotuzumab. Lenzilumab has potential for treatment of various rare diseases, including hematologic cancers such as chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML)
YEAR FOUNDED:
2000
LEADERSHIP:
CEO: Cameron Durrant
CSO: Morgan Lam
CFO: Dave Tousley

171 articles with Humanigen (Formerly Known As KaloBios Pharmaceuticals, Inc.)